What This Therapeutics Insider Signals Revenue Momentum
A high-profile insider sale at PTC Therapeutics coincides with a milestone for product revenue. This article breaks d...
Knowing when to start retirement discussions with a financial advisor can enhance your planning. Get the guidance you need to succeed.
20,658 articlesA high-profile insider sale at PTC Therapeutics coincides with a milestone for product revenue. This article breaks d...
Online buzz can influence money choices. This guide explains how analysis claims thousands bots may distort engagemen...
The Pentagon has formally designated Anthropic as a supply chain risk, a move that could curtail access to defense co...
Oil jolts can rattle markets fast. This guide explains why oil spikes matter for stocks, what history shows, and acti...
Oil prices hold near the high-$80s to low-$90s as the Hormuz disruption tests supply buffers. Market resilience is fu...
As Schwab prepares to report Q4 2025 results, investors want clarity on what drives earnings and where risks lie. Thi...
Markets wobbled as President Trump labeled Iran’s ceasefire reply 'TOTALLY UNACCEPTABLE,' fueling a risk-off mood ami...
As visa rules tighten, a growing share of U.S. firms with immigrant leaders are scrambling to secure continuity throu...
OpenAI's Sam Altman and Anthropic's Dario Amodei are dialing back their earlier fears about AI wiping out white-colla...
The White House announced a sweeping executive order that reclassifies about 8,000 senior federal employees, allowing...
A veteran investor argues Talen Energy is undervalued versus its replacement cost, with potential for a doubling or m...
Two very different corners of the consumer space compete for attention in 2026: fashion-forward American Eagle Outfit...